Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引:24
|
作者
Bansal, Amar D. [1 ]
Hill, Chloe E. [2 ]
Berns, Jeffrey S. [1 ]
机构
[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;
D O I
10.1111/sdi.12385
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.
引用
收藏
页码:404 / 412
页数:9
相关论文
共 50 条
  • [31] CALCIPHYLAXIS IN THE ABSENCE OF CHRONIC KIDNEY DISEASE OR END-STAGE RENAL DISEASE
    Raiasekaran, Arun
    Ashton, Rebecca
    Patni, Hitesh
    Kar, Pran
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A80 - A80
  • [32] Dyslipidemia in chronic kidney disease and end-stage renal disease: A review
    Appel, GB
    Appel, AS
    DIALYSIS & TRANSPLANTATION, 2004, 33 (11) : 714 - +
  • [33] The management of chronic kidney disease and end-stage renal disease in Nigeria
    Agaba, Emmanuel I.
    Tzamaloukas, Antonios H.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 653 - 654
  • [34] Exercise for children with chronic kidney disease and end-stage renal disease
    Emma L. Clapp
    Alan Bevington
    Alice C. Smith
    Pediatric Nephrology, 2012, 27 : 165 - 172
  • [35] Pregnancy in advanced chronic kidney disease and end-stage renal disease
    Alkhunaizi, Ahd
    Melamed, Nir
    Hladunewich, Michelle A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (03): : 252 - 259
  • [36] Economic Issues of Chronic Kidney Disease and End-Stage Renal Disease
    Takemoto, Yoshiaki
    Naganuma, Toshihide
    CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 87 - 93
  • [37] The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease
    Wang, Virginia
    Vilme, Helene
    Maciejewski, Matthew L.
    Boulware, L. Ebony
    SEMINARS IN NEPHROLOGY, 2016, 36 (04) : 319 - 330
  • [38] The management of chronic kidney disease and end-stage renal disease in Nigeria
    Emmanuel I. Agaba
    Antonios H. Tzamaloukas
    International Urology and Nephrology, 2012, 44 : 653 - 654
  • [39] Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease
    Lin, Ming-Yen
    Chiu, Yi-Wen
    Chang, Jung-San
    Lin, Hung-Lung
    Lee, Charles Tzu-Chi
    Chiu, Guei-Fen
    Kuo, Mei-Chuan
    Wu, Ming-Tsang
    Chen, Hung-Chun
    Hwang, Shang-Jyh
    KIDNEY INTERNATIONAL, 2015, 88 (06) : 1365 - 1373
  • [40] Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis
    Chang, Tara I.
    Zheng, Yuanchao
    Montez-Rath, Maria E.
    Winkelmayer, Wolfgang C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (08): : 1401 - 1412